Impact of age and gender interaction on circulating endothelial progenitor cells in healthy subjects

Fertility and Sterility

Volumn 93, Issue 3, 2010, Pages 843-846

  Rousseau, Alexandra ^a   Ayoubi, Fida ^b   Deveaux, Christel ^a   Charbit, Beny ^a   Delmau, Catherine ^b   Christin Maitre, Sophie ^c   Jaillon, Patrice ^a   Uzan, Georges ^b   Simon, Tabassome ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b HÔPITAL PAUL BROUSSE   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

cardiovascular risk; Endothelial progenitor cells; estrogen; menopause

Indexed keywords

SEX HORMONE;

ADULT; AGE; ARTICLE; CELL COUNT; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HUMAN; MALE; MENOPAUSE; MENSTRUAL CYCLE; NORMAL HUMAN; PRIORITY JOURNAL; SEX DIFFERENCE; STEM CELL;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; ESTRADIOL; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MENOPAUSE; MENSTRUAL CYCLE; RISK FACTORS; SEX CHARACTERISTICS; SEX DISTRIBUTION; TESTOSTERONE; YOUNG ADULT;

EID: 75949117510     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.10.062     Document Type: Article

References (21)

1. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Schmidt-Lucke C., Rossig L., Fichtlscherer S., Vasa M., Britten M., Kamper U., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005) 2981-2987
3. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
4. Werner N., and Nickenig G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?. Arteriosclerosis, thrombosis, and vascular biology 26 (2006) 257-266
5. American Heart Association. Heart and stroke statistical 2007 update (2006), American Heart Association, Dallas, TX
6. Hodis H.N., and Mack W.J. Atherosclerosis imaging methods: assessing cardiovascular disease and evaluating the role of estrogen in the prevention of atherosclerosis. Am J Cardiol 89 (2002) 19E-27E discussion 27E
7. Mendelsohn M.E. Protective effects of estrogen on the cardiovascular system. Am J Cardiol 89 (2002) 12E-17E discussion 7E-8E
8. Buemi M., Allegra A., D'Anna R., Coppolino G., Crasci E., Giordano D., et al. Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension. Am J Obstet Gynecol 196 (2007) 68.e1-68.e6
9. Sugawara J., Mitsui-Saito M., Hoshiai T., Hayashi C., Kimura Y., and Okamura K. Circulating endothelial progenitor cells during human pregnancy. J Clin Endocrinol Metab 90 (2005) 1845-1848
10. Strehlow K., Werner N., Berweiler J., Link A., Dirnagl U., Priller J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 107 (2003) 3059-3065
11. Bulut D., Albrecht N., Imohl M., Gunesdogan B., Bulut-Streich N., Borgel J., et al. Hormonal status modulates circulating endothelial progenitor cells. Clin Res Cardiol 96 (2007) 258-263
12. Masuda H., Kalka C., Takahashi T., Yoshida M., Wada M., Kobori M., et al. Estrogen-mediated endothelial progenitor cell biology and kinetics for physiological postnatal vasculogenesis. Circ Res 101 (2007) 598-606
13. Avouac J., Juin F., Wipff J., Couraud P.O., Chiocchia G., Kahan A., et al. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann Rheum Dis 67 (2008) 1455-1460
14. Rehman J., Li J., Parvathaneni L., Karlsson G., Panchal V.R., Temm C.J., et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J Am Coll Cardiol 43 (2004) 2314-2318
15. McCullagh P., and Nelder J. Generalized linear models. 2nd ed (1999), Chapman & Hall/CRC, Boca Raton, FL
16. Hill J.M., Zalos G., Halcox J.P., Schenke W.H., Waclawiw M.A., Quyyumi A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348 (2003) 593-600
17. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89 (2001) E1-E7
18. Hoetzer G.L., MacEneaney O.J., Irmiger H.M., Keith R., Van Guilder G.P., Stauffer B.L., et al. Gender differences in circulating endothelial progenitor cell colony-forming capacity and migratory activity in middle-aged adults. Am J Cardiol 99 (2007) 46-48
19. Sugawara J., Mitsui-Saito M., Hayashi C., Hoshiai T., Senoo M., Chisaka H., et al. Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. J Clin Endocrinol Metab 90 (2005) 5329-5332
20. Fadini G.P., de Kreutzenberg S., Albiero M., Coracina A., Pagnin E., Baesso I., et al. Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arteriosclerosis, thrombosis, and vascular biology 28 (2008) 997-1004
21. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958